FDG-PET Imaging for Hodgkin and Diffuse Large B-Cell Lymphoma-An Updated Overview.

Hodgkin lymphoma diffuse large B-cell lymphoma positron emission tomography response assessment staging

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
05 Mar 2020
Historique:
received: 14 01 2020
revised: 02 03 2020
accepted: 03 03 2020
entrez: 11 3 2020
pubmed: 11 3 2020
medline: 11 3 2020
Statut: epublish

Résumé

Since the mid-1990s,

Identifiants

pubmed: 32150986
pii: cancers12030601
doi: 10.3390/cancers12030601
pmc: PMC7139791
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Déclaration de conflit d'intérêts

There are no conflicts of interest to declare.

Références

J Clin Oncol. 2017 Jun 1;35(16):1786-1794
pubmed: 28291393
Ann Oncol. 2008 Oct;19(10):1770-3
pubmed: 18550578
Br J Haematol. 2019 Aug;186(3):431-439
pubmed: 31115045
J Clin Oncol. 2019 Jul 10;37(20):1732-1741
pubmed: 31112475
Blood. 2018 Jan 4;131(1):84-94
pubmed: 29038339
J Clin Oncol. 2009 Apr 10;27(11):1781-7
pubmed: 19273712
Eur J Nucl Med Mol Imaging. 2016 Jul;43(7):1209-19
pubmed: 26902371
J Clin Oncol. 2014 Apr 10;32(11):1112-8
pubmed: 24493716
Ann Oncol. 2018 Oct 1;29(Suppl 4):iv19-iv29
pubmed: 29796651
J Clin Oncol. 1988 Jun;6(6):931-3
pubmed: 3373263
Ann Oncol. 2003 Jan;14(1):123-30
pubmed: 12488304
Lancet. 2020 Dec 21;394(10216):2271-2281
pubmed: 31868632
J Clin Oncol. 2012 Dec 20;30(36):4508-14
pubmed: 23150698
Ann Oncol. 2011 Mar;22(3):671-680
pubmed: 20693297
Eur J Cancer. 2020 Jan;124:25-36
pubmed: 31710995
Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):310-316
pubmed: 29222272
Br J Haematol. 2001 Nov;115(2):272-8
pubmed: 11703321
J Nucl Med. 2020 Jan;61(1):40-45
pubmed: 31201248
Am J Hematol. 2015 Aug;90(8):686-90
pubmed: 25925613
Blood. 2018 Nov 22;132(21):2273-2279
pubmed: 30166329
Ann Oncol. 2010 Jun;21(6):1222-1227
pubmed: 19901011
J Clin Oncol. 2015 Aug 10;33(23):2523-9
pubmed: 26150440
J Clin Oncol. 2020 Nov 20;38(33):3905-3913
pubmed: 32946355
Leuk Lymphoma. 2009 Aug;50(8):1257-60
pubmed: 19544140
Eur J Nucl Med Mol Imaging. 2014 Jun;41(6):1133-40
pubmed: 24570095
J Clin Oncol. 2018 Feb 10;36(5):454-462
pubmed: 29360414
N Engl J Med. 2010 Aug 12;363(7):640-52
pubmed: 20818855
Theranostics. 2015 Mar 01;5(6):618-30
pubmed: 25825601
Clin Nucl Med. 2017 Aug;42(8):595-602
pubmed: 28604477
Lancet Oncol. 2019 Feb;20(2):202-215
pubmed: 30658935
Leuk Lymphoma. 2012 Jan;53(1):64-70
pubmed: 21740300
Radiology. 2007 Jul;244(1):257-62
pubmed: 17581905
J Clin Oncol. 2013 Feb 20;31(6):684-91
pubmed: 23182987
J Nucl Med. 2019 Aug;60(8):1096-1102
pubmed: 30954945
J Clin Oncol. 2018 Jul 10;36(20):2024-2034
pubmed: 29750632
J Clin Oncol. 2014 Sep 20;32(27):3059-68
pubmed: 25113753
Blood. 2008 Nov 15;112(10):3989-94
pubmed: 18757777
Lancet. 2018 Dec 23;390(10114):2790-2802
pubmed: 29061295
Ann Oncol. 2006 Jan;17(1):117-22
pubmed: 16192294
J Clin Oncol. 2014 Jun 10;32(17):1776-81
pubmed: 24799482
JAMA Oncol. 2020 Jun 1;6(6):872-880
pubmed: 32352505
Eur J Nucl Med Mol Imaging. 2021 Oct;48(11):3550-3559
pubmed: 33928400
J Nucl Med. 2009 May;50 Suppl 1:122S-50S
pubmed: 19403881
Ann Oncol. 2018 Sep 1;29(9):1926-1931
pubmed: 30010775
Lancet Oncol. 2013 Sep;14(10):943-52
pubmed: 23948348
Blood. 2021 Feb 18;137(7):929-938
pubmed: 32871586
EJNMMI Res. 2019 Oct 29;9(1):95
pubmed: 31664529
Cancer Res. 2015 Jul 15;75(14):2928-36
pubmed: 25977331
J Clin Oncol. 2011 Sep 10;29(26):3523-8
pubmed: 21825262
Blood. 2001 Nov 15;98(10):2930-4
pubmed: 11698273
J Nucl Med. 2014 Oct;55(10):1591-7
pubmed: 25214642
J Nucl Med. 2018 Jun 7;:
pubmed: 29880508
Leuk Lymphoma. 2019 Jun;60(6):1389-1398
pubmed: 30507313
Med Clin (Barc). 2007 Nov 17;129(18):688-93
pubmed: 18021609
J Clin Oncol. 2019 Nov 1;37(31):2835-2845
pubmed: 31498753
Eur J Nucl Med Mol Imaging. 2010 Jun;37(6):1095-105
pubmed: 20204358
Blood. 2017 Sep 14;130(11):1315-1326
pubmed: 28701367
Eur J Nucl Med Mol Imaging. 2013 Sep;40(9):1312-20
pubmed: 23649463
N Engl J Med. 2015 Apr 23;372(17):1598-607
pubmed: 25901426
Ann Oncol. 2016 Jun;27(6):1095-1099
pubmed: 27002106
J Nucl Med. 2014 Apr;55(4):569-73
pubmed: 24566003
J Nucl Med. 2019 Jun;60(6):801-805
pubmed: 30954939
N Engl J Med. 2016 Jun 23;374(25):2419-29
pubmed: 27332902
Blood. 2016 Mar 24;127(12):1531-8
pubmed: 26747247
Nucl Med Commun. 2016 Jan;37(1):23-9
pubmed: 26440567
Ann Oncol. 2015 Sep;26 Suppl 5:v116-25
pubmed: 26314773
Lancet Oncol. 2008 Feb;9(2):105-16
pubmed: 18226581
Cancer Res. 1971 Nov;31(11):1860-1
pubmed: 5121694
Blood. 1999 Jul 15;94(2):429-33
pubmed: 10397709
Ann Hematol. 2019 Apr;98(4):897-907
pubmed: 30610279
Nucl Med Commun. 2019 Mar;40(3):249-257
pubmed: 30461699
Ann Oncol. 2017 Jul 1;28(7):1436-1447
pubmed: 28379322
Blood. 2020 Apr 16;135(16):1396-1405
pubmed: 31978225
PET Clin. 2020 Jan;15(1):35-43
pubmed: 31735300
N Engl J Med. 1993 Sep 30;329(14):987-94
pubmed: 8141877
Radiology. 2014 Jul;272(1):262-74
pubmed: 24708193
J Clin Oncol. 2011 May 10;29(14):1812-26
pubmed: 21483001
Ann Oncol. 2001 Jan;12(1):29-37
pubmed: 11249046
Blood. 2013 Jul 4;122(1):61-7
pubmed: 23660958
Blood. 2018 Mar 29;131(13):1456-1463
pubmed: 29437590

Auteurs

Conrad-Amadeus Voltin (CA)

Department of Nuclear Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne 50937, Germany.

Jasmin Mettler (J)

Department of Nuclear Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne 50937, Germany.

Jirka Grosse (J)

Department of Nuclear Medicine, University Hospital Regensburg, Regensburg 93053, Germany.

Markus Dietlein (M)

Department of Nuclear Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne 50937, Germany.

Christian Baues (C)

Department of Radiation Oncology and Cyberknife Center, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne 50937, Germany.

Christine Schmitz (C)

Department of Hematology, West German Cancer Center (WTZ), University Hospital Essen, University of Duisburg-Essen, Essen 45147, Germany.

Peter Borchmann (P)

Department of Internal Medicine I, Center for Integrated Oncology Aachen-Bonn-Cologne-Dusseldorf (CIO ABCD), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne 50937, Germany.

Carsten Kobe (C)

Department of Nuclear Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne 50937, Germany.

Dirk Hellwig (D)

Department of Nuclear Medicine, University Hospital Regensburg, Regensburg 93053, Germany.

Classifications MeSH